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Abstract
Background: Apolipoprotein (Apo) B is the major component of low-density lipoprotein (LDL), very low-density lipoprotein
(VLDL) and chylomicrons. Many genetic polymorphisms of the Apo B have been described, associated with variation of lipid
levels. However, very few studies have evaluated the effect of the variable number of tandem repeats region 3' of the Apo B
gene (3'APOB-VNTR) polymorphism on the lipid profiles in the special minority subgroups in China. Thus, the present study
was undertaken to study the effect of the 3'APOB-VNTR polymorphism on the serum lipid levels in the Guangxi Hei Yi Zhuang
and Han populations.
Methods:  A total of 548 people of Hei Yi Zhuang were surveyed by a stratified randomized cluster sampling. The
epidemiological survey was performed using internationally standardized methods. Serum lipid and apolipoprotein levels were
measured. The 3'APOB-VNTR alleles were determined by polymerase chain reaction (PCR) followed by electrophoresis in
polyacrylamide gels, and classified according to the number of repeats of a 15-bp hypervariable elements (HVE). The sequence
of the most common allele was determined using the PCR and direct sequencing. The possible association between alleles of
the 3'APOB-VNTR and lipid variables was examined. The results were compared with those in 496 people of Han who also live
in that district.
Results: Nineteen alleles ranging from 24 to 64 repeats were detected in both Hei Yi Zhuang and Han. HVE56 and HVE58 were
not be detected in Hei Yi Zhuang whereas HVE48 and HVE62 were totally absent in Han. The frequencies of HVE26, HVE30,
HVE46, heterozygote, and short alleles (< 38 repeats) were higher in Hei Yi Zhuang than in Han. But the frequencies of HVE34,
HVE38, HVE40, homozygote, and long alleles (≥ 38 repeats) were lower in Hei Yi Zhuang than in Han (P < 0.05–0.01). The levels
of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and Apo B in Hei Yi Zhuang but not in Han were higher
in VNTR-LS (carrier of one long and one short alleles) than in VNTR-LL (the individual carrying two long alleles) genotypes. The
levels of TC, triglycerides (TG), LDL cholesterol, and Apo B in Hei Yi Zhuang were higher in both HVE34 and HVE36 alleles
than in HVE32 allele. The levels of TC, TG, HDL-C and Apo B in Hei Yi Zhuang were also higher in homozygotes than in
heterozygotes. There were no significant differences in the detected lipid parameters between the VNTR-SS (carrier of two
short alleles) and VNTR-LS or VNTR-LL genotypes in both ethnic groups.
Conclusion: There were significant differences of the 3'APOB-VNTR polymorphism between the Hei Yi Zhuang and Han
populations. An association between the 3'APOB-VNTR polymorphism and serum lipid levels was observed in the Hei Yi Zhuang
but not in the Han populations.
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Background
Coronary heart disease (CHD) is the main cause of death
in most industrialized nations, and is of growing concern
in developing countries. Disorders of lipid metabolism
such as elevated serum levels of total cholesterol (TC) [1-
3], triglycerides (TG) [4,5], low-density lipoprotein cho-
lesterol (LDL-C) [6,7], and apolipoprotein (Apo) B [8-11]
have been considered important risk factors in the patho-
genesis of atherosclerosis and CHD [12]. Apo B is the
main protein component of LDL, very low-density lipo-
protein (VLDL) and chylomicrons and plays an important
role in cholesterol metabolism [13,14]. It is involved in
the assembly and secretion of chylomicrons from the
small intestine and VLDL-C from the liver [15]. The Apo B
gene is a tissue-specific gene that is expressed mainly in
liver and intestine [16,17]. Numerous polymorphisms of
the Apo B gene have been described. Particularly, a varia-
ble number of tandem repeats (VNTR) polymorphism,
which is located 75 bp downstream the second polyade-
nylation signal at the 3' end of the Apo B gene (2p24-p23)
has been found to be common in some ethnic groups [18-
21], and it has been reported to be associated with modi-
fications of lipid concentrations [22-28] and the risk of
CHD [25-30] in some studies but not in others [31,32].
There are fifty-six nationalities in China. Han is the largest
nationality, and Zhuang is the largest minority. Geo-
graphically and linguistically, Zhuang can be classified
into 43 ethnic subgroups, among which Hei Yi (means
black-worship and black dressing) Zhuang is proved to be
the most conservative subgroup. They hold that black
color is beautiful, and they like to wear black garments
and pants. Black color has become the marking of Hei Yi
Zhuang. The population of Hei Yi Zhuang is 51,655.
Because of remoteness, continuous mountains, blocking,
abominable environment, as well as strict intra-ethnic
marriages, the special customs and culture are still pre-
served up to now. We have previously reported the differ-
ences of the serum lipid parameters [33,34], and the
effects of the microsomal triglyceride transfer protein gene
and the lipoprotein lipase gene polymorphism at Pvu II
locus on the lipid profiles between the Hei Yi Zhuang and
Han populations [35,36]. The aim of the present study
was to assess the effect of the 3'APOB-VNTR polymor-
phism on serum lipid levels in the Guangxi Hei Yi Zhuang
and Han populations.
Methods
Subjects
A total of 548 people of Hei Yi Zhuang who reside in 7 vil-
lages in Napo County, Guangxi Zhuang Autonomous
Region were surveyed by a stratified randomized cluster
sampling. The age of the subjects ranged from 15 to 80
years, with an average age of 45.78 ± 16.33 years. There
were 290 males (52.92%) and 258 females (47.08%). All
subjects were peasants. At the same time, a total of 496
people of Han who reside in 9 villages in Napo County
were also surveyed by the same method. The average age
of the subjects was 45.24 ± 15.87 years (range 15 to 82).
There were 264 males (53.23%) and 232 females
(46.77%). All of them were also peasants. All of these sub-
jects were essentially healthy and had no evidence of dis-
eases related to atherosclerosis. None of them had been
treated with β-adrenergic blocking agents and lipid-lower-
ing drugs such as statins or fibrates. The present study was
approved by the Ethics Committee of the First Affiliated
Hospital, Guangxi Medical University. Informed consent
was obtained from all subjects after they received a full
explanation of the study.
Epidemiological survey
The survey was carried out using internationally standard-
ized methods, following a common protocol. Informa-
tion on demographics (age, gender, and residential area),
socioeconomic status (education level achieved, marital
status, and annual household income), cigarette smoking,
alcohol consumption, and physical activity was collected
with a standardized questionnaire. Smoking status was
categorized into groups of cigarettes per day: <20 and ≥
20. Alcohol consumption was categorized into groups of
grams of wine per day: ≤ 250 g and >250 g. The physical
examination included several anthropometric parameters
such as blood pressure, body height, body weight, and
waist circumference etc., and body mass index (BMI) was
calculated as weight (kg) divided by height (m) squared.
Sitting blood pressure was measured three times with the
use of a mercury sphygmomanometer after the subject rest
5 minutes, and the average of the three measurements was
used for the level of blood pressure. Systolic blood pres-
sure was determined by the first Korotkoff sound, and
diastolic blood pressure by the fifth Korotkoff sound.
Measurements of lipids and apolipoproteins
A venous blood sample of 8 mL was obtained from all
subjects between 8 and 11 AM, after at least 12 hours of
fasting, from a forearm vein after venous occlusion for few
seconds in a sitting position. 3 mL was collected into glass
tubes and allowed to clot at room temperature, and used
to determine serum lipids, and the remaining 5 mL was
transferred to tubes with anticoagulate solution (4.80 g/L
citric acid, 14.70 g/L glucose, and 13.20 g/L tri-sodium cit-
rate) and used to extract DNA. Immediately following
clotting serum was separated by centrifugation for 15
minutes at 3000 rpm. The levels of TC, TG, high-density
lipoprotein cholesterol (HDL-C), and LDL-C in samples
were determined by enzymatic methods with commer-
cially available kits, Tcho-1, TG-LH (RANDOX Laborato-
ries Ltd., Ardmore, Diamond Road, Crumlin Co. Antrim,
United Kingdom, BT29 4QY), Cholestest N HDL, and
Cholestest LDL (Daiichi Pure Chemicals Co., Ltd., Tokyo,BMC Medical Genetics 2007, 8:45 http://www.biomedcentral.com/1471-2350/8/45
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Japan), respectively. Serum Apo A1 and Apo B levels were
assessed by the immunoturbidimetric immunoassay
using a commercial kit (RANDOX Laboratories Ltd.). All
determinations were performed with an autoanalyzer
(Type 7170A; Hitachi Ltd., Tokyo, Japan) in the Clinical
Science Experiment Center of the First Affiliated Hospital,
Guangxi Medical University.
Deoxyribonucleic acid extraction
Genomic deoxyribonucleic acid (DNA) was extracted
from the peripheral blood leukocytes by the phenol-chlo-
roform method as our previous reports [35,36]. The
extracted DNA was stored at 4°C until analysis.
Determination of the 3'APOB-VNTR polymorphism
Amplification of genomic DNA
Apo B 3'VNTR amplification was carried out by polymer-
ase chain reaction (PCR) using a forward and reverse oli-
gonucleotide primer encompassing the entire Apo B
3'VNTR sequence according to the previously reported
protocol [29,37-39]. The sequence of the forward and
backward primers used was 5'-ATGGAAACGGAGAAAT-
TATG-3' and 5'-CCTTCTCACTTGGCAAATAC-3'. Each
amplification reaction was performed with 100 ng (3 μL)
of genomic DNA; 1.0 μL of each primer (20 pmo1); 5 μL
of 10 × buffer solution; 4 μL dNTP; and 1.0 μL (2 U) Taq
polymerase a total volume of 50 μL. For the amplification,
initial denaturation at 94°C for 5 minutes was followed
by 30 cycles of denaturation at 94°C for 40 s, annealing at
58°C for 80 s, and extension at 72°C for 1 minute, with
final extension at 72°C for 10 min. The amplified prod-
ucts were directly observed after electrophoresis in 2%
sepharose gel.
Genotyping of the 3'APOB-VNTR polymorphism
To separate the 3' VNTR alleles, 15 μL of amplified DNA
were run on 6% polyacrylamide gel at 20 mA for 5 hours.
Stained with ethidium bromide, the gel was visualized
under UV light and photographed. The length of each
amplified DNA fragment was determined by comparing
migration of a sample with that of standard DNA marker.
The number of tandem repeats was calculated using the
equation: repeat number = [fragment length (bp) - 138
bp] / 15 bp. The nomenclature proposed by Ludwig et al
[39] was used in this study. One short DNA sequence at
the 3' boundary of the hypervariable region was regarded
as a repeat [40].
DNA sequencing
Genomic DNA was chosen from the subjects carrying
HVE32 of Hei Yi Zhuang and was amplified by symmetric
PCR. The PCR product was purified by low melting point
gel electrophoresis and phenol extraction. The products
were analyzed by using an ABI Prism 3100 (Applied Bios-
yatems) in our Medical Scientific Research Center,
Guangxi Medical University, China.
Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C, Apo
A1, and Apo B in our Clinical Science Experiment Center
were 3.10–5.17, 0.56–1.70, 0.91–1.81, 1.70–3.20 mmol/
L, 1.00–1.76, and 0.63–1.14 g/L; respectively. The indi-
viduals of TC >5.17 mmol/L and/or TG >1.70 mmol/L
should be defined as hyperlipidemic [33,34]. Hyperten-
sion was diagnosed according to the criteria of 1999
World Health Organization-International Society of
Hypertension Guidelines for the management of hyper-
tension [41]. Uncontrolled hypertension was defined as a
systolic blood pressure of 140 mmHg or greater and a
diastolic blood pressure of 90 mmHg or greater. The sub-
jects with only systolic blood pressure = 140 mmHg but
diastolic blood pressure <90 mmHg were diagnosed as
isolated systolic hypertension. The diagnostic criteria of
overweight and obesity were according to the Coorpera-
tive Meta-analysis Group of China Obesity Task Force.
Normal weight, overweight and obesity were defined as a
BMI <24, 24–28, and >28 kg/m2, respectively [42].
Statistical analysis
Epidemiological data were recorded on a pre-designed
form and managed with Excel software. Levels of the
quantitative variables are presented as mean ± standard
deviation (SD). The difference of general characteristics
between Hei Yi Zhuang and Han was tested by the Stu-
dent's unpaired t test. The allele frequencies of DNA poly-
morphism of the Apo B gene were estimated by gene
counting. A chi-square analysis was used to evaluate the
allelic and genotypic frequencies that were calculated
from the observed genotypic counts and to assess Hardy-
Weinberg expectations. One-way analysis of variance
(ANOVA) was used to assess the differences of lipid varia-
bles among 3 genotypes. Significant difference was then
subjected to multiple comparison using the Newman-
Keuls. In order to evaluate the association of serum lipid
levels with sex (male = 0; female = 1), age (year), cigarette
smoking (nonsmokers = 0; <20 cigarettes/day = 1; ≥ 20
cigarettes/day = 2), alcohol consumption (nondrinkers =
0; ≤ 250 g wine/day = 1; >250 g/day = 2), BMI (kg/m2),
pulse pressure (mmHg), unconditional logistic regression
analysis with forward stepwise modeling was also per-
formed in the population. All statistical analyses were
done with the statistical software package SPSS 10.0 (SPSS
Inc., Chicago, Illinois). A P value of less than 0.05 was
considered significant.
Results
General characteristics
Table 1 gives the general characteristics of the subjects
between Hei Yi Zhuang and Han. The levels of systolicBMC Medical Genetics 2007, 8:45 http://www.biomedcentral.com/1471-2350/8/45
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blood pressure and pulse pressure were significantly
higher in Hei Yi Zhuang than in Han (P < 0.01 for each),
whereas body weight and BMI were higher in Han than in
Hei Yi Zhuang (P <0.05 and 0.01; respectively). There
were no significant differences of body height, diastolic
blood pressure levels, age and sex constituent ratio
between the Hei Yi Zhuang and Han subjects.
Serum lipid levels
As shown in Table 2, the levels of TC, TG, LDL-C, and Apo
B in Hei Yi Zhuang were significantly lower than those in
Han (P < 0.05–0.01), but the levels of HDL-C in Hei Yi
Zhuang were significantly higher than those in Han (P <
0.01). There were no significant differences of Apo A1 lev-
els between the two ethnic groups (P > 0.05).
Allelic frequencies
Using the PCR followed by electrophoresis in polyacryla-
mide gels and classifying according to the number of
repeats of a 15-bp hypervariable elements (HVE), 19 dif-
ferent alleles of the Apo B gene 3'VNTR comprising from
24 to 64 HVEs were identified in both Hei Yi Zhuang and
Han (Table 3, Figures 1 and 2). They were 24, 26, 28, 30,
32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 60, 62 and
64 repeats in Hei Yi Zhuang, and 24, 26, 28, 30, 32, 34,
36, 38, 40, 42, 44, 46, 50, 52, 54, 56, 58, 60 and 64 repeats
in Han. HVE56 and HVE58 were not be detected in Hei Yi
Zhuang and HVE48 and HVE62 were not be found in
Han. The most frequent allele was HVE32 (25.9%), fol-
lowed by HVE34 (20.6%) and HVE30 (16.9%) in Hei Yi
Zhuang, whereas the most frequent allele was HVE34
(27.2%), followed by HVE32 (23.7%) and HVE36
(15.3%) in Han. The frequencies of HVE26, HVE30,
HVE46, heterozygote, and short alleles (<38 repeats) were
higher in Hei Yi Zhuang than in Han (2.9% vs. 0.3%, P <
0.01; 16.9% vs. 5.7%, P < 0.01; 1.2% vs. 0.3%, P < 0.05;
50.4% vs. 34.6%, P < 0.01 and 86.0% vs. 77.8%, P < 0.01;
respectively), whereas the frequencies of HVE34, HVE38,
HVE40, homozygote, and long alleles (≥ 38 repeats) were
lower in Hei Yi Zhuang than in Han (20.6% vs. 27.2%, P
< 0.05; 4.1% vs. 9.6%, P < 0.01; 2.2% vs. 4.5%, P < 0.01;
49.6% vs. 65.4%, P < 0.01 and 14.0% vs. 22.2%, P < 0.01;
respectively). No allele less than 24 was found in both
ethnic groups (Figure 3).
3'APOB-VNTR polymorphism and serum lipid levels
By re-coding the 3'APOB-VNTR alleles into long and short
alleles, we found that there were significant differences of
the long or short allele frequency between Hei Yi Zhuang
and Han (P < 0.01). The levels of TC, HDL-C and Apo B
in Hei Yi Zhuang but not in Han were higher in VNTR-LS
(carrier of one long and one short alleles) genotype than
in VNTR-LL (the individual carrying two long alleles) gen-
otype. However, there were no significant differences of
TC, TG, HDL-C, LDL-C, and Apo Al levels between VNTR-
SS (carrier of two short alleles) genotype and VNTR-LS or
VNTR-LL genotype in Hei Yi Zhuang. There were also no
significant differences of TC, TG, HDL-C, LDL-C, Apo Al
and Apo B levels among the three genotypes in Han (P >
0.05, Table 4).
In order to evaluate the effects of allele frequency on the
serum lipid levels, the three most common forms
(HVE32, HVE34 and HVE36) in both ethnic groups were
also be calculated separately. We found that the levels of
TC in HVE34, and TG, LDL-C and Apo B in both HVE34
and HVE36 alleles were higher than those in HVE32
allele, whereas the levels of HDL-C in HVE32 allele were
higher than those in both HVE34 and HVE36 alleles in
Hei Yi Zhuang group. In Han populations, the levels of TC
in HVE34, TG in HVE36, and LDL-C in both HVE34 and
HVE36 alleles were higher than those in HVE32 allele
(Table 5).
For further analysis of 3'APOB-VNTR allele frequency and
its possible association with serum lipid levels, all
3'APOB-VNTR alleles were grouped into two main types
(homozygotes and heterozygotes). The subjects of
homozygote and heterozygote were 272 (49.6%) and 276
(50.4%) in Hei Yi Zhuang, and 324 (65.4%) and 172
(34.6%) in Han (P < 0.01); respectively. The levels of TC,
TG, HDL-C and Apo B in Hei Yi Zhuang but not in Han
were higher in homozygotes than in heterozygotes. There
were no significant differences of Apo Al levels between
the homozygotes and heterozygotes in both ethnic groups
(P > 0.05, Table 6).
Relative factors of serum lipid levels
Multivariate logistic regression analysis showed that the
levels of TC, HDL-C, Apo A1, and Apo B were positively
correlated with age (P < 0.05–0.001), respectively. The
levels of TG, HDL-C, and Apo A1 were positively corre-
lated with alcohol consumption (P < 0.01–0.001), respec-
tively, whereas the levels of LDL-C and Apo B were
negatively associated with alcohol consumption (P  <
0.001 and 0.05; respectively). The levels of HDL-C, LDL-
C, and Apo A1 were positively correlated with sex (P <
0.05–0.001, Table 7), respectively. There is no significant
correlation between the levels of TC, TG, HDL-C, LDL-C,
Apo A1, and Apo B and cigarette smoking, BMI, pulse
pressure (P > 0.05).
Oligonucleotide sequence of the HVE 32 of the 3'APOB-
VNTR gene
The oligonucleotide sequence of the PCR product of
HVE32 is shown in Table 8 and Figure 4, using the
nomenclature initially proposed by Ludwig et al [39]. The
first AT repeat sequence (ATAATTAAATATTTT) was
defined as X type, and the second repeat sequence
(ATAATTAAAATATTT) was defined as Y type. Thus, theBMC Medical Genetics 2007, 8:45 http://www.biomedcentral.com/1471-2350/8/45
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oligonucleotide sequence of the HVE 32 of the 3'APOB-
VNTR gene is XYY(XY)5(Xii Yii)2(Xii Yii)4Yii(Xi Yi)2Xii Xi.
Discussion
The current study shows that the levels of serum TC, TG,
LDL-C and Apo B in Hei Yi Zhuang were significantly
lower than those in Han, whereas the levels of HDL-C in
Hei Yi Zhuang were significantly higher than those in
Han. There were no significant differences of Apo A1 lev-
els between the two ethnic groups. These findings are in
agreement with those of our previous studies [33,34]. It
has been suggested that hyperlipidemia is a complex trait
caused by multiple environmental and genetic factors.
Genetic factors can account for approximately one-half of
the variation in plasma LDL-C concentration in humans
[43], considerable efforts have been made during the past
decade to define mutations associated with hypercholes-
terolemia. Several studies have demonstrated that the var-
iability of 3' Apo B polymorphism not only in distant
populations but also, to a certain extent, in genetically rel-
ative ones [18-21]. Hei Yi Zhuang is a specific subgroup of
Zhuang nationality in China. Strict intra-ethnic marriages
have been performed from time immemorial in this
nationality. Namely, only both man and woman are Hei
Yi Zhuang can marry, and can not intermarry with the
other subgroups of Zhuang or other nationalities [33,34].
Therefore, we are confident that the genetic factors are
involved in the results of the present study. The hereditary
characteristic and gene phenotypes of lipids in Hei Yi
Zhuang may be different from those in Han.
In the present study, we showed that there were consider-
able differences of the 3'APOB-VNTR alleles between Hei
Yi Zhuang and Han. Hei Yi Zhuang is devoid of the
HVE56 and HVE58, whereas Han is short of the HVE48
and HVE62. The most frequent allele in Hei Yi Zhuang is
VNTR32 (25.9%), followed by 34 and 30 repeats whose
frequencies are 20.6% and 16.9% respectively, whereas
the most frequent allele in Han is HVE34 (27.2%), fol-
lowed by HVE32 (23.7%) and HVE36 (15.3%). The fre-
Table 1: Comparison of general characteristics between the Hei Yi Zhuang and Han populations
Parameters Hei Yi Zhuang Han Nationality
Number 548 496
Sex (male/female) 290/258 264/232
Age (year) 45.78 ± 16.33 45.24 ± 15.87
Body height (cm) 152.76 ± 9.57 152.88 ± 8.74
Body weight (kg) 49.13 ± 8.43 50.58 ± 8.62*
Body mass index (kg/m2) 21.26 ± 2.12 22.58 ± 2.57**
Systolic blood pressure (mmHg) 125.79 ± 17.36 118.75 ± 16.73**
Diastolic blood pressure (mmHg) 76.86 ± 11.24 76.46 ± 10.36
Pulse pressure (mmHg) 49.14 ± 13.57 44.27 ± 11.62**
Cigarette smoking [n(%)]
Nonsmoker 352(64.23) 356(71.77)*
<20 cigarettes/day 114(20.81) 66(13.31)*
≥20 cigarettes/day 82(14.96) 74(14.92)
Alcohol consumption [n(%)]
Nondrinker 246(44.89) 260(52.42)**
≤250 g wine/day 224(40.88) 180(36.29)
>250 g wine/day 78(14.23) 56(11.29)
*P < 0.01 and **P < 0.001 in comparison with Hei Yi Zhuang
Table 2: Comparison of serum lipid levels between the Hei Yi Zhuang and Han populations
Nationality/sex n TC
(mmol/L)
TG
(mmol/L)
HDL-C
(mmol/L)
LDL-C
(mmol/L)
Apo A1
(g/L)
Apo B
(g/L)
Hei Yi Zhuang 548 4.44 ± 0.96 1.07 ± 0.61 2.53 ± 0.72 2.11 ± 0.55 1.43 ± 0.14 0.86 ± 0.19
Male 290 4.46 ± 0.94 1.14 ± 0.75 2.63 ± 0.74 2.09 ± 0.59 1.43 ± 0.14 0.88 ± 0.21
Female 258 4.45 ± 0.96 0.97 ± 0.42†† 2.48 ± 0.67† 2.12 ± 0.51 1.42 ± 0.15 0.85 ± 0.20
Han nationality 496 4.73 ± 1.02** 1.21 ± 0.71** 2.31 ± 0.75** 2.42 ± 0.57** 1.42 ± 0.13 1.19 ± 0.22**
Male 264 4.82 ± 1.16** 1.24 ± 0.83 2.34 ± 0.82** 2.56 ± 0.45** 1.41 ± 0.15 1.32 ± 0.23
Female 232 4.63 ± 0.92†* 1.18 ± 0.65** 2.27 ± 0.67** 2.36 ± 0.42††** 1.43 ± 0.12 0.98 ± 0.21††**
TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Apo A1, 
apolipoprotein A1; Apo B, apolipoprotein B; †P < 0.05 and ††P < 0.01 in comparison with male of same nationality; *P < 0.05 and **P < 0.01 in 
comparison with Hei Yi ZhuangBMC Medical Genetics 2007, 8:45 http://www.biomedcentral.com/1471-2350/8/45
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quencies of HVE26, HVE30, HVE46, heterozygote, and
short alleles were higher in Hei Yi Zhuang than in Han,
whereas the frequencies of HVE34, HVE38, HVE40,
homozygote, and long alleles were lower in Hei Yi
Zhuang than in Han, suggesting that the allelic variation
of the 3'APOB-VNTR polymorphism may have an associ-
ation with various ethnic groups. Alavantic et al [22]
found the HVE containing 34 repeats-HVE34 allele to be
the most common one in both female and male samples
from the Belgrade area, and that there was a lower fre-
quency of the HVE>36 alleles. Verbenko et al [19] have
reported that 25 alleles of the 3' ApoB minisatellite, rang-
ing from 25 to 55 repeats, were detected in healthy unre-
lated individuals from the Russian Federation and the
Table 3: Comparison of the allelic frequencies of the 3'APOB-VNTR polymorphism in the Hei Yi Zhuang and Han populations [n(%)]
Alleles Hei Yi Zhuang Han Nationality
HVE24 4(0.5) 2(0.3)
HVE26 24(2.9) 2(0.3)**
HVE28 56(6.8) 36(5.4)
HVE30 140(16.9) 38(5.7)**
HVE32 214(25.9) 158(23.7)
HVE34 170(20.6) 182(27.2)**
HVE36 102(12.3) 102(15.3)
HVE38 34(4.1) 64(9.6)**
HVE40 18(2.2) 30(4.5)*
HVE42 14(1.7) 10(1.5)
HVE44 8(1.0) 4(0.6)
HVE46 10(1.2) 2(0.3)*
HVE48 4(0.5) 0(0.0)
HVE50 4(0.5) 8(1.2)
HVE52 8(1.0) 8(1.2)
HVE54 4(0.5) 2(0.3)
HVE56 0(0.0) 2(0.3)
HVE58 0(0.0) 8(1.2)
HVE60 6(0.7) 4(0.6)
HVE62 4(0.5) 0(0.0)
HVE64 2(0.2) 6(0.9)
Sum 826(100) 668(100)
≥38 116(14.0) 148(22.2)**
<38 710(86.0) 520(77.8)**
HVE, hypervariable element; *P < 0.05 and **P < 0.01 in comparison with Hei Yi Zhuang
Table 4: Comparison of the lipid and apolipoprotein levels in the genotypes of the 3'APOB-VNTR polymorphism between the Hei Yi 
Zhuang and Han populations
Nationality/Genotype n TC
(mmol/L)
TG
(mmol/L)
HDL-C
(mmol/L)
LDL-C
(mmol/L)
Apo A1
(g/L)
Apo B
(g/L)
Hei Yi Zhuang
VNTR-SS 186 4.39 ± 0.84 1.00 ± 0.47 2.22 ± 0.69 2.00 ± 0.56 1.41 ± 0.15 0.84 ± 0.20
VNTR-LS 80 4.56 ± 0.94 1.06 ± 0.49 2.38 ± 0.77 2.03 ± 0.42 1.42 ± 0.14 0.90 ± 0.24#
VNTR-LL 12 3.89 ± 0.70† 0.76 ± 0.16 1.83 ± 0.47† 2.09 ± 0.50 1.43 ± 0.08 0.69 ± 0.16#††
F -- 3.411 2.209 3.640 0.231 0.211 5.909
P -- <0.05 >0.05 <0.05 >0.05 >0.05 <0.01
Han Nationality
VNTR-SS 88 4.78 ± 0.88** 1.10 ± 0.62 2.50 ± 0.71** 2.00 ± 0.40 1.44 ± 0.11 0.92 ± 0.21**
VNTR-LS 74 4.57 ± 1.00 1.20 ± 0.54 2.40 ± 0.79 2.00 ± 0.42 1.42 ± 0.14 0.90 ± 0.24
VNTR-LL 10 4.68 ± 0.93* 1.12 ± 0.56* 2.39 ± 0.73* 2.01 ± 0.40 1.49 ± 0.05 0.91 ± 0.22*
F -- 1.011 0.599 0.396 0.003 1.654 0.160
P -- >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Apo A1, 
apolipoprotein A1; Apo B, apolipoprotein B; #P < 0.05 in comparison withVNTR-SS genotype; †P < 0.05 and ††P < 0.01 in comparison with VNTR-
LS genotype; *P < 0.05 and **P < 0.01 in comparison with Hei Yi ZhuangBMC Medical Genetics 2007, 8:45 http://www.biomedcentral.com/1471-2350/8/45
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Republic of Belarus, in 10 populations from five ethnic
groups: Russians, Byelorussians, Adygeis, Kalmyks and
Yakuts. Heterozygosity indices were high and varied from
0.73 to 0.84. The distributions of alleles of this minisatel-
lite in the Caucasoid populations (Russians, Byelorus-
sians and Adygeis) had a bimodal character, whereas that
for Mongoloid populations (Kalmyks and Yakuts) had a
unimodal distribution. In a study of allelic frequency dis-
tribution at the hypervariable locus 3' to the Apo B gene
in 5 human populations (Kacharis of northeast India,
New Guinea Highlanders of Papua New Guinea, Dogrib
Indians of Canada, Pehuenche Indians of Chile, and a rel-
atively homogeneous Caucasian population of northern
German extraction), Deka et al [44] also found 12 segre-
gating alleles in 319 individuals. The two most frequent
alleles, 37 and 39, were present in all the populations. In
the present study, we found that alleles 56 and 58 were
completely absent in Hei Yi Zhuang but present in Han,
while alleles 48 and 62 were absent in Han but present in
Hei Yi Zhuang. This clearly demonstrates the presence of
allelic frequency variation in different populations. These
association studies may be of some use when genetic fac-
tors are considered as one of the predisposing causes.
The potential relationships in humans between polymor-
phisms in the Apo B gene and the plasma or serum levels
of Apo B-containing lipoproteins have been evaluated in
a large number of studies [22-28]. Several reports docu-
mented associations between polymorphisms of the Apo
B gene locus and LDL-C levels, but not one of these asso-
ciations has been consistently observed in a large number
of studies. Indeed, none of the common polymorphisms
analyzed thus far has been generally accepted as a genetic
marker of hyperlipidemia. Moreover, it is largely
unknown whether any of the Apo B polymorphisms are
linked directly to changes in Apo B metabolism. In the
present study, we showed that the levels of TC, HDL-C
and Apo B in Hei Yi Zhuang but not in Han were higher
in VNTR-LS than VNTR-LL genotypes. The levels of TC in
HVE34, and TG, LDL-C and Apo B in both HVE34 and
HVE36 alleles were higher than those in HVE32 allele,
whereas the levels of HDL-C in HVE32 allele were higher
than those in both HVE34 and HVE36 alleles in Hei Yi
Zhuang group. The levels of TC in HVE34, TG in HVE36,
and LDL-C in both HVE34 and HVE36 alleles were higher
than those in HVE32 allele in Han populations. The levels
of TC, TG, HDL-C and Apo B in Hei Yi Zhuang were also
higher in homozygotes than in heterozygotes. The reason
for this discrepancy between the two ethnic groups is
Electrophoretic result of PCR products of the samples in Hei  Yi Zhuang Figure 2
Electrophoretic result of PCR products of the samples in Hei 
Yi Zhuang. Lane M, 322 bp marker ladder (PBR322/MspI); 
Lanes 1–3, 5, 8–10, 12–14, 17, and 18, heterozygotes (two 
straps); Lanes 4, 6, 7, 11, 15, and 16, homozygotes (one 
strap)
 
Electrophoretic result of PCR products of the samples in  Han Figure 1
Electrophoretic result of PCR products of the samples in 
Han. Lane M, 322 bp marker ladder (PBR322/MspI); Lane 2, 
heterozygote (two straps); Lanes 1, 3–10, homozygotes (one 
strap)BMC Medical Genetics 2007, 8:45 http://www.biomedcentral.com/1471-2350/8/45
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unclear. Our findings in Hei Yi Zhuang, however, are sim-
ilar to those previously described in several studies [22-
28]. In a healthy population sample from the Belgrade
area, Alavantic et al [22] found that the HVE32 allele was
associated with decreased serum levels of TC, LDL-C, and
TG, and the 3'APOB-VNTR genotypes containing HVE34
and HVE36 alleles were associated with elevated serum
levels of TC, LDL-C, and TG in males. In the obese people,
Jemaa et al [23] found that the subjects with 50 repeat
allele had significantly higher BMI, and subjects with 32
repeat allele had significantly higher HDL-C and ApoA1
levels. By the analysis of the healthy sample group, Gar-
asto et al [24] found that the S (Short, <35 repeats) alleles
lower the average values of serum TC and LDL-C while the
alleles  M  (Medium, 35–39 repeats) and L  (Long, >39
repeats) have no significant effect on the lipidemic pheno-
type. Studies that considered polymorphisms within the
Apo B gene as risk factors for CHD have also reported con-
flicting results. Friedl et al [25] showed that the alleles
containing 38, 44, 46, or 48 HVEs had an association with
CHD. These alleles were also associated with elevated
serum levels of TC and Apo B among patients and with
elevated serum levels of TG among controls. Pan et al [26]
showed CHD patients with two HVE36 alleles and no
HVE32 alleles (the two most common forms) had signif-
icantly higher concentrations of LDL-C, Apo B, and TG,
and significantly lower values of HDL-C and Apo A1 than
the control group. The length of the Apo B 3' VNTR was
not correlated with the plasma concentrations of any of
the lipids. In a recent report, Yan et al [30] found that
APOB gene 3'VNTR polymorphism exerts an impact on
lipid metabolism and may contribute to the susceptibility
to the development of CHD in Han Chinese. The fre-
quency of 3'VNTR-B alleles (HVE = 38) in the CHD cases
was higher than that of the controls. 3'VNTR-B allele was
dependently related to TC levels. Compared with SS
homozygotes, 3'VNTR-B allele carriers were associated
with an increased risk of CHD. No significant differences
in the internal structure and sequences of APOB gene
3'VNTR alleles were found between cases and controls. In
a previous study, however, Hegele et al [45] found a sig-
nificant correlation between Apo B gene polymorphisms
and CHD, without any significant association with either
LDL or VLDL. There was also no significant association
between the 3'VNTR alleles and serum lipid levels in the
Table 5: Effects of HVE32, HVE34, and HVE36 alleles on the lipid and apolipoprotein levels between the Hei Yi Zhuang and Han 
populations
Nationality/
Allele
n TC
(mmol/L)
TG
(mmol/L)
HDL-C
(mmol/L)
LDL-C
(mmol/L)
Apo A1
(g/L)
Apo B
(g/L)
Hei Yi Zhuang
HVE32 214 3.98 ± 0.78 0.99 ± 0.48 2.47 ± 0.71 1.96 ± 0.55 1.43 ± 0.15 0.78 ± 0.20
HVE34 170 4.36 ± 0.91## 1.16 ± 0.52## 2.26 ± 0.68## 2.14 ± 0.64## 1.42 ± 0.14 0.91 ± 0.23##
HVE36 102 4.14 ± 0.73† 1.23 ± 0.46## 2.13 ± 0.59## 2.18 ± 0.57## 1.41 ± 0.11 0.86 ± 0.22##
F -- 10.221 10.241 9.955 0.231 0.751 17.741
P -- <0.001 <0.001 <0.05 >0.05 >0.05 <0.001
Han Nationality
HVE32 158 4.79 ± 1.02** 1.10 ± 0.74 2.52 ± 0.75 1.97 ± 0.65 1.43 ± 0.13 0.89 ± 0.20**
HVE34 182 4.54 ± 0.89# 1.23 ± 0.65 2.41 ± 0.80 2.32 ± 0.73##* 1.45 ± 0.15 0.94 ± 0.23
HVE36 102 4.72 ± 0.96** 1.36 ± 0.77# 2.35 ± 0.71* 2.24 ± 0.64## 1.44 ± 0.14 0.90 ± 0.21
F -- 3.078 4.220 1.714 11.716 0.854 2.471
P -- <0.05 <0.05 >0.05 <0.001 >0.05 >0.05
TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Apo A1, 
apolipoprotein A1; Apo B, apolipoprotein B; #P < 0.05 and ##P < 0.01 in comparison with HVE32 allele; †P < 0.05 in comparison with HVE34 allele; 
*P < 0.05 and **P < 0.01 in comparison with Hei Yi Zhuang
The frequency distribution of the 3'APOB-VNTR alleles  between the Hei Yi Zhuang and Han populations; P < 0.05  (HVE40 and HVE46) and P < 0.01 (HVE26, HVE30, HVE34  and HVE38), in comparison between Hei Yi Zhuang and Han Figure 3
The frequency distribution of the 3'APOB-VNTR alleles 
between the Hei Yi Zhuang and Han populations; P < 0.05 
(HVE40 and HVE46) and P < 0.01 (HVE26, HVE30, HVE34 
and HVE38), in comparison between Hei Yi Zhuang and Han.BMC Medical Genetics 2007, 8:45 http://www.biomedcentral.com/1471-2350/8/45
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Finnish population [31]. Similar results were reported in
a porcine model of atherosclerosis in which an Apo B
genetic variant was associated with atherosclerosis,
despite normal lipid levels [46]. We surmise that the dis-
crepancy may be related to the difference of ethnic groups.
In addition to the genetic factors, environmental factors
such as diet may also paly an important role in determing
the levels of these lipid phenotypes. In the present study,
we showed that the levels of TC, HDL-C, Apo A1, and Apo
B were positively correlated with age, respectively. The lev-
els of TG, HDL-C, and Apo A1 were positively correlated
with alcohol consumption, respectively, whereas the lev-
els of LDL-C and Apo B were negatively associated with
alcohol consumption; respectively. There is no significant
correlation between the levels of TC, TG, HDL-C, LDL-C,
Apo A1, and Apo B and cigarette smoking, BMI, and pulse
pressure. Although Hei Yi Zhuang and Han live in the
same region, the risk factors as mentioned above might be
dissimilar. Great majority of Hei Yi Zhuang people live in
the mountainous areas. The staple food is corn gruel or
corn tortillas. On ordinary days, they are vegetarians.
About 95% of the beverage is corn wine and rum. While
Han takes rice as the staple food mostly. The standard of
living in Han is higher than that in Hei Yi Zhuang. The
intake of animal fat is more than that in Hei Yi Zhuang,
Table 7: Relationship between the lipid paramerers and relative factors
Lipid paramerers Relative factors Regression 
coefficient
Standard error SRC tp
TC Age (years) 0.011 0.004 0.230 2.764 0.006
TG Alcohol 
consumption (g/
day)
0.550 0.191 0.240 2.887 0.005
HDL-C Age (years) 0.004 0.002 0.126 2.132 0.034
Sex 0.172 0.072 0.161 2.387 0.018
Alcohol 
consumption (g/
day)
0.315 0.081 0.265 3.898 0.000
LDL-C Sex 0.010 0.002 0.258 4.416 0.000
Alcohol 
consumption (g/
day)
-0.291 0.090 -0.188 -3.222 0.001
Apo A1 Age (years) 0.002 0.000 0.278 4.977 0.000
Sex 0.051 0.019 0.175 2.745 0.006
Alcohol 
consumption (g/
day)
0.104 0.021 0.319 4.968 0.000
Apo B Age (years) 0.003 0.001 0.310 0.310 0.000
Alcohol 
consumption (g/
day)
-0.057 0.026 -0.124 -2.140 0.033
TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Apo A1, 
apolipoprotein A1; Apo B, apolipoprotein B; SRC, standardized regression coefficient
Table 6: Comparison of the lipid and apolipoprotein levels in the subjects of homozygote and heterozygote between the Hei Yi Zhuang 
and Han populations
Nationality n TC
(mmol/L)
TG
(mmol/L)
HDL-C
(mmol/L)
LDL-C
(mmol/L)
Apo A1
(g/L)
Apo B
(g/L)
Hei Yi Zhuang
Homozygote 272 4.62 ± 1.02 1.12 ± 0.71 2.37 ± 0.68 2.14 ± 0.55 1.43 ± 0.15 0.89 ± 0.19
Heterozygot
e
276 4.41 ± 0.87†† 1.00 ± 0.46† 2.25 ± 0.71† 2.07 ± 0.52 1.42 ± 0.14 0.85 ± 0.21†
Han Nationality
Homozygote 324 4.75 ± 1.01 1.18 ± 0.75 2.51 ± 0.73* 1.96 ± 0.45** 1.43 ± 0.14 0.95 ± 0.21**
Heterozygot
e
172 4.66 ± 1.00** 1.10 ± 0.62 2.46 ± 0.73** 2.02 ± 0.41 1.43 ± 0.13 0.91 ± 0.22†**
TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Apo A1, 
apolipoprotein A1; Apo B, apolipoprotein B; †P < 0.05 and ††P < 0.01 in comparison with homozygote of same nationality; *P < 0.05 and **P < 0.01 
in comparison with Hei Yi ZhuangBMC Medical Genetics 2007, 8:45 http://www.biomedcentral.com/1471-2350/8/45
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and the body weight and BMI are also significantly higher
than those in Hei Yi Zhuang [33,34]. For nearly 50 y it has
been widely accepted that high-fat diets, particularly those
that contain large quantities of saturated fatty acids, raise
blood cholesterol concentrations and predispose individ-
uals to cardiovascular disease [47]. In addition, the other
major causation of different lipid levels between Hei Yi
Zhuang and Han may relate to the excessive intake of
corn. Corn contains abundant dietary fiber and plant
high-quality protein [48]. Consumption of dietary fiber,
specifically the soluble type, such a pectins and guar gum
can result in a decrease of serum cholesterol levels in
healthy and hyperlipidemic subjects [49]. Plant protein
might raise the serum levels of HDL-C, and promote the
transportation and excretion of free cholesterol. Corn oil
is a kind of edible oils that is enriched with polyunsatu-
rated fatty acid and monounsaturated fatty acid [50], and
it is mostly used for cooking by Hei Yi Zhuang. A great
deal of research has indicated that suitable intakes of pol-
yunsaturated fatty acid and monounsaturated fatty acid
can lower the serum levels of cholesterol and LDL-C
[51,52]. A potential beneficial effect of dietary monoun-
saturated fatty acid on HDL-C has been suggested [52].
Corn oil could increase the ratio of HDL-C to TC and
decrease the ratio of LDL-C to HDL-C [50].
In the present study, we also showed that the oligonucle-
otide sequence of the HVE32 of the 3'APOB-VNTR is
somewhat different from that of a previous report [53]. In
a previous structural and functional study of Apo B gene
3'VNTR alleles in Han Chinese, Chen et al [53] have
described that the oligonucleotide sequence of the HVE32
of the 3'APOB-VNTR is XYX(XY)5(XYii)2(Xii-
Yii)3XiiXiiYiii(XiiYi)2XiiXi or XYX(XY)5(XYii)2(Xii-
Yii)4XiiXiiYiii(XiiYi)2XiiXi. In the present study, we
showed that the oligonucleotide sequence of the HVE32
of the 3'APOB-VNTR in Hei Yi Zhuang is XYY(XY)5(Xii-
Yii)2(XiiYii)4Yii(XiYi)2XiiXi, suggesting that the multi-
formity of the 3'APOB-VNTR polymorphism includes not
only in the variable numbers of the repeat unit, but also
in the variation in the oligonucleotide sequence within
the repeat units as well as the variation in the arrangement
of the repeat units [54].
Conclusion
In conclusion, the current study shows that there were sig-
nificant differences of the 3'APOB-VNTR polymorphism
between Hei Yi Zhuang and Han. The levels of TC, HDL-
C and Apo B in Hei Yi Zhuang but not in Han were higher
in VNTR-LS than in VNTR-LL genotypes. The 3'APOB-
VNTR genotypes containing HVE34 and HVE36 alleles
were associated with elevated serum levels of TC, TG, LDL-
C, and Apo B in Hei Yi Zhuang. The favorable lipid pro-
files of Hei Yi Zhuang might result from the effects of both
environmental and genetic factors.
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Table 8: The oligonucleotide sequence of the HVE 32 of the 3'APOB-VNTR gene in the Hei Yi Zhuang
5'-TTAAAAGATGAGGCCCTGTGTTTTT
ATAATTAAATATTTT ATAATTAAAATATTT ATAATTAAAATATTT ATAATTAAATATTTT
XYYX
ATAATTAAAATATTT ATAATTAAAATATTT ATAATTAAAATATTT ATAATTAAATATTTT
YXYX
ATAATTAAAATATTT ATAATTAAATATTTT ATAATTAAAATATTT ATAATTAAATATTTT
YXYX
ATAATTAAAATGTTT ATAATTAAATATTTT ATAATTAAAATGTTT ATAATTACATATTTT
YX Y i i X
ATAATTAAAATGTTT ATAATTACATATTTT ATAATTAAAATGTTT ATAATTACATATTTT
Yii Xii Yii Xii
ATAATTAAAATGTTT ATAAAGTATTT ATAATTACATATTTT ATAATTAAAGTATTT
Yii Yii Xii Yi
ATAATTACATATTTT ATAATTAAAGTATTT ATAATTACATATTTT ATAATTCAATATTTT
Xii Yi Xii Xi
ATAAATAGTTAAAAAGACGAGGAAAATTAAAAGACGAGGTTATTGATCTCAGGAATTGTAT
TCGCCCACGCGGAGAAGGA-3'
Sequence: XYY(XY)5(Xii Yii)2(Xii Yii)4Yii(Xi Yi)2Xii XiBMC Medical Genetics 2007, 8:45 http://www.biomedcentral.com/1471-2350/8/45
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The oligonucleotide sequence of the HVE 32 of the 3'APOB-VNTR gene in the Hei Yi Zhuang Figure 4
The oligonucleotide sequence of the HVE 32 of the 3'APOB-VNTR gene in the Hei Yi Zhuang.BMC Medical Genetics 2007, 8:45 http://www.biomedcentral.com/1471-2350/8/45
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